Finance

Lists
PLYX:NASDAQ
Polaryx Therapeutics, Inc
$2.09
-0.48%
(-0.0100) 1D
Aug 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLYX...
Open
$2.13
High
$2.16
Low
$2.06
Mkt. cap
104.18M
Avg. vol.
104.94K
Volume
0.00
52-wk high
$48.91
52-wk low
$1.87
No. of employees
7
Open
$2.13
High
$2.16
Low
$2.06
Mkt. cap
104.18M
Avg. vol.
104.94K
Volume
0.00
52-wk high
$48.91
52-wk low
$1.87
No. of employees
7
About Polaryx Therapeutics, Inc
CEO-
Employees7
Founded2014
HeadquartersParamus, New Jersey, United States
SectorPharmaceutical industry
Websitepolaryx.com
Analyst ratings
Based on 2 analysts giving stock ratings to PLYX in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PLYX in the last 3 months.
Highest
Current $2.09
$7.00 (+234.93%)
Average
$6.50 (+211.00%)
Lowest
$6.00 (+187.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tiago Fauth
Raymond James
Buy
Initiated
$6.00
+187.1%
08/13/2026
Dev Prasad
Lucid Capital
Buy
Initiated
$7.00
+234.9%
07/27/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+378.5%
04/21/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
514.00K
560.00K
679.00K
719.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
460.00K
351.00K
1.28M
661.00K
Operating expense
974.00K
911.00K
1.96M
1.38M
Total operating expenses
974.00K
911.00K
1.96M
1.38M
Operating income
-974.00K
-911.00K
-1.96M
-1.38M
Other non operating income
-456.00K
-584.00K
-586.00K
-
EBT including unusual items
-1.43M
-1.50M
-2.54M
-1.38M
EBT excluding unusual items
-1.43M
-1.50M
-2.54M
-1.38M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.43M
-1.50M
-2.54M
-1.38M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps